Analyze Diet
Veterinary clinical pathology2026; doi: 10.1111/vcp.70100

The Effect of Lipemia on Insulin and Adiponectin Measurement in Equine Blood Samples.

Abstract: Lipemia is a common comorbidity in horses with obesity or equine metabolic syndrome, but the impact of lipemia on the measurement of insulin and adiponectin has not been evaluated. Objective: To evaluate endogenous and exogenous lipemic interference with equine insulin and adiponectin measurements via several commercial assays. Methods: Endogenous lipemia was evaluated using plasma and serum samples with triglyceride concentrations of  1000 mg/dL (n = 6 each). Sample insulin concentrations were determined via fluorescence enzyme immunoassay (FEIA), ELISA, and lateral flow assay (LFA). Test agreement was assessed using Pearson's correlation coefficient, Passing-Bablok regression, and Bland-Altman analysis. Exogenous lipemia was evaluated using pools of serum, plasma, and whole blood (n = 5 each) spiked with Intralipid 20% to triglyceride concentrations of 0, 50, 100, 250, 500, and 1000 mg/dL. Insulin concentrations were measured via FEIA, ELISA, and LFA, and adiponectin concentrations via immunoturbidometric assay (ITA). Interferograms were created and a Kruskal-Wallis test was used to compare bias between triglyceride concentrations. Results: With endogenous lipemia, agreement between the three assays was excellent (r > 0.90) with no appreciable impact of triglyceride concentration. For exogenous lipemia, significant (p < 0.05) negative interference was observed at triglyceride concentrations of 1000 mg/dL with the insulin ELISA using plasma. No significant interference was found for the insulin ELISA or FEIA using serum, insulin LFA using whole blood or plasma, or adiponectin ITA using serum. Conclusions: Falsely low insulin values may be obtained at high triglyceride concentrations with the insulin ELISA using plasma.
Publication Date: 2026-02-16 PubMed ID: 41699877DOI: 10.1111/vcp.70100Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigates how lipemia (high blood fat levels) affects the accuracy of insulin and adiponectin measurements in horses, particularly those with metabolic issues.
  • The research compares different assay methods to see if lipemia causes false readings in blood tests commonly used for diagnosing equine metabolic syndrome.

Background and Purpose

  • Lipemia, characterized by elevated triglycerides in the blood, frequently occurs in horses with obesity or equine metabolic syndrome (EMS).
  • Accurate measurement of insulin and adiponectin is critical for diagnosing and monitoring EMS, but the impact of lipemia on these measurements was unclear prior to this study.
  • The study aimed to evaluate both endogenous (naturally occurring) and exogenous (artificially added) lipemia interference on insulin and adiponectin assays.

Methods

  • Samples: Blood samples were collected from horses, including:
    • Plasma and serum samples with endogenous triglyceride concentrations >1000 mg/dL (6 samples each).
    • Pools of serum, plasma, and whole blood (5 samples each) artificially spiked with Intralipid 20% to adjust triglyceride levels from 0 to 1000 mg/dL.
  • Assays used:
    • Insulin was measured by:
      • Fluorescence enzyme immunoassay (FEIA)
      • ELISA (enzyme-linked immunosorbent assay)
      • Lateral flow assay (LFA)
    • Adiponectin was measured via immunoturbidometric assay (ITA).
  • Data Analysis:
    • Agreement between assays was assessed with Pearson’s correlation, Passing-Bablok regression, and Bland-Altman analysis.
    • Effects of varying triglyceride concentrations (especially at 1000 mg/dL) were evaluated with interferograms and the non-parametric Kruskal-Wallis test to determine bias.

Results

  • Endogenous Lipemia:
    • High triglyceride blood samples showed excellent agreement between all three insulin assays (correlation coefficient r > 0.90).
    • No significant effect of naturally high triglycerides on insulin or adiponectin measurements was observed.
  • Exogenous Lipemia:
    • When triglyceride concentrations were artificially increased, a significant negative interference was detected only with the insulin ELISA in plasma samples at 1000 mg/dL triglycerides (p < 0.05).
    • No significant interference was seen with:
      • Insulin ELISA or FEIA using serum samples.
      • Insulin LFA using whole blood or plasma.
      • Adiponectin ITA using serum.

Conclusions and Implications

  • Lipemia generally does not interfere with the accuracy of insulin and adiponectin assays in horses under typical clinical conditions.
  • However, extremely high triglyceride levels (≥1000 mg/dL) can cause falsely low insulin readings specifically when using the insulin ELISA on plasma samples.
  • Clinicians should be cautious interpreting low insulin results from plasma ELISA tests in lipemic horses, considering alternative assay methods or sample types.
  • Using serum samples or other assays like FEIA or LFA may reduce the risk of lipemia-related measurement errors.

Summary

  • This study provides important guidance to veterinarians on the reliability of insulin and adiponectin tests for horses with lipemia, ensuring better diagnostics and management of equine metabolic problems.
  • It encourages awareness of assay-specific limitations and supports using appropriate methods to avoid diagnostic errors due to blood fat interference.

Cite This Article

APA
Hallowell KL, van Eps AW, Kulp JC, Schnabel LV. (2026). The Effect of Lipemia on Insulin and Adiponectin Measurement in Equine Blood Samples. Vet Clin Pathol. https://doi.org/10.1111/vcp.70100

Publication

ISSN: 1939-165X
NlmUniqueID: 9880575
Country: United States
Language: English

Researcher Affiliations

Hallowell, Kimberly L
  • Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
van Eps, Andrew W
  • Department of Clinical Studies, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.
Kulp, Jeaneen C
  • Department of Clinical Studies, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.
Schnabel, Lauren V
  • Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
  • Comparative Medicine Institute, North Carolina State University, Raleigh, North Carolina, USA.

Grant Funding

  • Laminitis Research Fund, University of Pennsylvania
  • T32OD011130 / NIH HHS

References

This article includes 21 references
  1. Knowles EJ, Elliott J, Harris PA, Chang Y, Menzies‐Gow NJ. Predictors of Laminitis Development in a Cohort of Nonlaminitic Ponies. Equine Veterinary Journal 55, no. 1 (2022): 12–23.
    doi: 10.1111/evj.13572google scholar: lookup
  2. Menzies‐Gow NJ, Harris PA, Elliott J. Prospective Cohort Study Evaluating Risk Factors for the Development of Pasture‐Associated Laminitis in the United Kingdom. Equine Veterinary Journal 49, no. 3 (2017): 300–306.
    doi: 10.1111/evj.12606google scholar: lookup
  3. de Laat MA, Sillence MN, Reiche DB. Phenotypic, Hormonal, and Clinical Characteristics of Equine Endocrinopathic Laminitis. Journal of Veterinary Internal Medicine 33, no. 3 (2019): 1456–1463.
    doi: 10.1111/jvim.15419google scholar: lookup
  4. Bertin FR, Bailey S, Burns T. Recommendations for the Diagnosis and Management of Equine Metabolic Syndrome (EMS) and Insulin Dysregulation (Equine Endocrinol Group, 2024). .
  5. Nolen‐Walston RD, Kulp JC, Stefanovski D, van Eps AW. Evaluation of an Automated Fluorescence Enzyme Immunoassay for Quantification of Equine Insulin and Comparison to Five Other Immunoassays. Journal of Veterinary Internal Medicine 39, no. 2 (2025): e70038.
    doi: 10.1111/jvim.70038google scholar: lookup
  6. Berryhill EH, Urbina NS, Marton S, Vernau W, Alonso FH. Validation and Method Comparison for a Point‐Of‐Care Lateral Flow Assay Measuring Equine Whole Blood Insulin Concentrations. Journal of Veterinary Diagnostic Investigation 35, no. 2 (2023): 124–131.
    doi: 10.1177/10406387221142288google scholar: lookup
  7. Öberg J, Bröjer J, Wattle O, Lilliehöök I. Evaluation of an Equine‐Optimized Enzyme‐Linked Immunosorbent Assay for Serum Insulin Measurement and Stability Study of Equine Serum Insulin. Comparative Clinical Pathology 21, no. 6 (2012): 1291–1300.
  8. Go YY, Hazard NW, Balasuriya UBR. Clinical Evaluation of the Immulite 1000 Chemiluminescent Immunoassay for Measurement of Equine Serum Insulin. Frontiers in Veterinary Science 10 (2023): 1018230.
  9. Menzies‐Gow NJ, Knowles EJ, Rogers I, Rendle DI. Validity and Application of Immunoturbidimetric and Enzyme‐Linked Immunosorbent Assays for the Measurement of Adiponectin Concentration in Ponies. Equine Veterinary Journal 51, no. 1 (2019): 33–37.
    doi: 10.1111/evj.12960google scholar: lookup
  10. Flatland B, Freeman KP, Friedrichs KR. ASVCP Quality Assurance Guidelines: Control of General Analytical Factors in Veterinary Laboratories. Veterinary Clinical Pathology 39, no. 3 (2010): 264–277.
  11. Nikolac N, Simundic AM, Miksa M. Heterogeneity of Manufacturers' Declarations for Lipemia Interference–An Urgent Call for Standardization. Clinica Chimica Acta 426 (2013): 33–40.
    doi: 10.1016/j.cca.2013.08.015google scholar: lookup
  12. Nikolac N. Lipemia: Causes, Interference Mechanisms, Detection and Management. Biochemia Medica 24 (2014): 57–67.
    doi: 10.11613/bm.2014.008google scholar: lookup
  13. McKenzie HC. Equine Hyperlipidemias. Veterinary Clinics of North America. Equine Practice 27, no. 1 (2011): 59–72.
  14. Tóth B, Auth A, Rompos L, Bakos Z. Effect of Feed Deprivation on Selected Parameters of Lipid Mobilisation and Hepatic Function in Healthy Akhal Teke Horses. Equine Veterinary Journal 50, no. 1 (2018): 98–103.
    doi: 10.1111/evj.12730google scholar: lookup
  15. Sundra T, Knowles E, Rendle D, Kelty E, Lester G, Rossi G. Short‐Term Clinical and Biochemical Responses Following Treatment With Dapagliflozin or Ertugliflozin in Horses With Hyperinsulinemia: A Retrospective Case Series. Domestic Animal Endocrinology 90 (2025): 106894.
  16. Glick MR, Ryder KW, Jackson SA. Graphical Comparisons of Interferences in Clinical Chemistry Instrumentation. Clinical Chemistry 32, no. 3 (1986): 470–475.
    doi: 10.1093/clinchem/32.3.470google scholar: lookup
  17. Retzinger GS, DeAnglis AP, Patuto SJ. Adsorption of Fibrinogen to Droplets of Liquid Hydrophobic Phases. Arteriosclerosis, Thrombosis, and Vascular Biology 18, no. 12 (1998): 1948–1957.
    doi: 10.1161/01.atv.18.12.1948google scholar: lookup
  18. . The Adiponectin Turbidimetric Immunoassay Kit (Catalogue Number: 51010). .
  19. Çolak Samsum E, Sürer H, Bolat S, Şeneş M, Yücel D. Comparison of Lipemia Interference Created With Native Lipemic Material and Intravenous Lipid Emulsion in Emergency Laboratory Tests. Biochemia Medica 34, no. 2 (2024): 20701.
    doi: 10.11613/bm.2024.020701google scholar: lookup
  20. Bornhorst JA, Roberts RF, Roberts WL. Assay‐Specific Differences in Lipemic Interference in Native and Intralipid‐Supplemented Samples. Clinical Chemistry 50, no. 11 (2004): 2197–2201.
  21. Kroll MH, McCudden CR. Icteric, Lipemic and Turbid Samples. in Endogenous Interferences in Clinical Laboratory Tests, 1st ed. (De Gruyter, 2013), 83–99.

Citations

This article has been cited 0 times.